MedPath

A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Not Applicable
Completed
Conditions
Cholestasis
Interventions
Other: CO2 insufflation
Other: Room air insufflation
Registration Number
NCT00685386
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The purpose of this study it to conduct a randomized, controlled, double-blinded trial of carbon dioxide (CO2) versus air insufflation during endoscopic retrograde cholangiopancreatography (ERCP).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • age >= 18 years
  • referred for ERCP for any indication at UNC Hospitals
Read More
Exclusion Criteria
  • age < 18 years
  • COPD requiring oxygen or with known CO2 retention
  • any medical condition with known CO2 retention
  • medical instability making the procedure unsafe
  • absolute requirement for same-day second endoscopy
  • ERCP performed in the OR or under GA
  • inability to read or understand English
  • use of chronic opiates for pain
  • pregnant women
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ICO2 insufflation-
IIRoom air insufflationRoom air will be used for insufflation as the placebo comparator arm.
Primary Outcome Measures
NameTimeMethod
Abdominal pain (VAS).pre-procedure and up to 24 hours post-procedure.
Secondary Outcome Measures
NameTimeMethod
The extent of CO2 retention.Intra-procedure

Trial Locations

Locations (1)

University of North Carolina-Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath